Identifying and characterizing binding sites and assessing druggability

Journal of Chemical Information and Modeling

Volumn 49, Issue 2, 2009, Pages 377-389

  Halgren, Thomas A ^a  

^a SCHRÖDINGER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGANDS;

BIOLOGICAL RESPONSE; GRAPHICAL INFORMATION; LEAD OPTIMIZATION; LIGAND STRUCTURE; PUTATIVE BINDING SITES; SCALE VALIDATION; SITE IDENTIFICATION; STRUCTURE BASED DRUG DESIGNS;

BINDING SITES;

DRUG;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; METABOLISM; PROTEIN BINDING;

BINDING SITES; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING;

EID: 65249117514     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci800324m     Document Type: Article

References (36)

1. Levitt, D.; Banaszak, L. POCKET: A computer graphics method for identifying and displaying protein cavities and their surrounding amino acids. J. Mol. Graphics 1992, 10, 229-243.
2. Laskowski, R. SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions. J. Mol. Graphics 1995, 13, 323-330.
3. Peters, K. P.; Fauck, J.; Frommel, C. The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria. J. Mol. Biol. 1996, 256, 201-213.
4. Hendlich, M.; Rippmann, F.; Barnickel, G. LIGSITE: automatic and efficient detection of potential small-molecule binding sites in proteins. J. Mol. Graphics Modell. 1997, 15, 359-363.
5. Liang, J.; Edelsbrunner, H.; Woodward, C. Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design. Protein Sci. 1998, 7, 1884-1897.
6. Brady, G. P., Jr.; Stouten, P. F. Fast prediction and visualization of protein binding pockets with PASS. J. Comput.-Aided Mol. Des. 2000, 14, 383-401.
7. Blinkowski, T.; Naghibzadeh, S.; Liang, J. CASTp: computed atlas of surface topography of proteins. Nucleic Acids Res. 2003, 31, 3352-3355.
8. CSC: predicting ligand binding sites using the Connolly surface and degree of conservation. BMC Struct. Biol [Online] 2006, 6. http://www.biomedcentral.com/1472-6807/ 6/ 19 (accessed June 11, 2007).
9. An, J.; Totrov, M.; Abagyan, R. Comprehensive identification and classification of ligand-binding envelopes. Mol. Cell Proteomics 2005, 4, 752-761.
10. Nayal, M.; Honig, B. On the nature of cavities on protein surfaces: application to the identification of drug-binding sites. Proteins 2006, 63, 892-906.
11. Dennis, S.; Kortvelyesi, T.; Vajda, S. Computational mapping identifies the binding sites of organic solvents on proteins. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 4290-4295.
12. Kortvelyesi, T.; Silberstein, M.; Dennis, S.; Vajda, S. Improved mapping of protein binding sites. J. Comput.-Aided Mol. Des. 2003, 17, 173-186.
13. Ruppert, J.; Welch, W.; Jain, A. Automatic identification and representation of protein binding sites for molecular docking. Protein Sci. 1997, 6, 524-533.
14. Verdonk, M. L.; Cole, J. C.; Watson, P.; Gillet, V.; Willett, P. SuperStar: improved knowledge-based interaction fields for protein binding sites. J. Mol. Biol. 2001, 307, 841-859, 2001.
15. Bliznyuk, A.; Gready, J. Simple method for locating possible ligand binding sites on protein surfaces. J. Comput. Chem. 1999, 9, 983-988.
16. Cheng, A. C.; Coleman, R. G.; Smyth, K. T.; Cao, Q.; Soulard, P.; Caffrey, D. R.; Salzberg, A. C.; Huang, E. S. Structure-based maximal affinity model predicts small-molecule druggability. Nat. Biotechnol. 2007, 25, 71-75.
17. Coleman, R. G.; Salzberg, A.; Cheng, A. C. Structure-based identification of small molecule binding sites using a free-energy model. J. Chem. Inf. Model. 2006, 46, 2631-2637.
18. Joughin, B. A.; Tidor, B.; Yaffe, M. B. A computational method for the analysis and prediction of protein:phosphopeptide-binding sites. Protein Sci. 2005, 14, 131-139.
19. Brown, D.; Superti-Furga, G. Rediscovering the sweet spot in drug discovery. Drug Discovery Today 2003, 8, 1067-1077.
20. Hopkins, A. L.; Groom, C. R. The druggable genome. Nat. Rev. Drug Discovery 2002, 1, 727-730.
21. SiteMap, version 2.2 (2008 update release); Schrödinger, LLC: Portland, OR, 2008. Maestro, version 8.5; Schrödinger, LLC: Portland, OR, 2008. QikProp, version 2.5; Schrödinger, LLC: Portland, OR, 2006. OPLS-2001; Schrödinger, LLC: Portland, OR, 2008.
22. Halgren, T. New method for fast and accurate binding-site identification and analysis. Chem. Biol. Drug Des. 2007, 69, 146-148.
23. Wang, R.; Fang, X.; Lu, Y.; Yang, C.-Y.; Wang, S. The PDBbind database: methodologies and updates. J. Med. Chem. 2005, 48, 4111-4119. PDBbind database, version 2004; University of Michigan: Ann Arbor, MI, 2005.
24. Wermuth, C. G. The Practice of Medicinal Chemistry, 2nd ed.; Academic Press: London, U.K. and San Diego, CA, 2003.
25. Roehrig, S.; Straub, A.; Pohlman, J.; Lampe, T.; Pernerstorfer, J.; Schlemmer, K. H.; Reinemer, P.; Perzborn, E. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]- 1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor. J. Med. Chem. 2005, 48, 5900-5908. The crystallographic structure has been solved but does not appear to have been deposited. However, a factor Xa structure with a similar group in the S1 pocket has been deposited as PDB refcode lnfw.
26. Pinto, D. J. P.; Orwat, M. J.; Koch, S.; Rossi, K. A.; Alexander, R. S.; Smallwood, A.; Wong, P. C.; Rendina, A. R.; Luettgen, J. M.; Knabb, R. M.; He, K.; Xin, B.; Wexler, R. R.; Lam, P. Y. Discovery of l-(4-Methoxyphenyl)-7-oxo-6- (4-(2-oxopiperidin-l-yl)phenyl)-4,5,6,7-tet-rahydro-lH-pyrazolo[3,4-c] pyridine-3-carboxamide (Apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa. J. Med. Chem. 2007, 50, 5339-5356. The crystallographic structure is deposited as PDB refcode 2pl6.
27. Karlsberg. http://agknapp.chemie.fu-berlin.de/karlsberg (accessed Aug 23, 2008). Kieseritzky, G.; Knapp, E. W. Optimizing pKa computation in proteins with pH adapted conformations. Proteins: Struct., Funct, Bioinf. 2008, 71, 1335-1348.
28. Burgey, C. S.; Robinson, K. A.; Lyle, T. A.; Sanderson, P. E.; Lewis, S. D.; Lucas, B. J.; Krueger, J. A.; Singh, R.; Miller-Stein, C.; White, R. B.; Wong, B.; Lyle, E. A.; Williams, P. D.; Coburn, C. A.; Dorsey, B. D.; Barrow, J. C.; Stranieri, M. T.; Holahan, M. A.; Sitko, G. R.; Cook, J. J.; McMasters, D. R.; McDonough, C. M.; Sanders, W. M.; Wallace, A. A.; Clayton, F. C.; Bohn, D.; Leonard, Y. M.; Detwiler, T. J., Jr.; Lynch, J. J., Jr.; Yan, Y.; Chen, Z.; Kuo, L.; Gardell, S. J.; Shafer, J. A.; Vacca, J. P. Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines. J. Med. Chem. 2003, 46, 461-473. Crystallographic structures are deposited as PDB refcodes lmu6, lmu8, and lmue.
29. Weber, A.; Halgren, T. A. Design and synthesis of P2-Pl′-linked macrocyclic human renin inhibitors. J. Med. Chem. 1991, 34, 2692-2701.
30. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28, 849-857.
31. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shaw, D. E.; Shelley, M.; Perry, J. K.; Francis, P.; Shenkin, P. S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 2004, 47, 1739-1749.
32. Halgren, T. A.; Murphy, R. B.; Friesner, R. A.; Beard, H. S.; Frye, L. L.; Pollard, W. T.; Banks, J. L. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 2004, 47, 1750-1759.
33. Friesner, R. A.; Murphy, R. B.; Repasky, M. P.; Frye, L. L.; Greenwood, J. R.; Halgren, T. A.; Sanschagrin, P. C.; Mainz, D. T. Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 2006, 49, 6177-6196.
34. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
35. Oprea, T. I.; Davis, A. M.; Teague, S. J.; Leeson, P. D. Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Model. 2001, 41, 1308-1315.
36. Therien, M.; Skorey, K.; Zamboni, R.; Li, C. S.; Lau, C. K.; LeRiche, T.; Truong, V. L.; Waddleton, D.; Ramachandran, C. Synthesis of a novel peptidic photoaffinity probe for the PTP-1B enzyme. Bioorg. Med. Chem. Lett. 2004, 14, 2319-2322.